Skip to content
Accessibility help
Search NICE…
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
In consultation
In consultation: Guidance and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Deferred
Awaiting development
Topic prioritisation
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Consultation end date
Consultation end date
From date
To date
Apply date filters
Type
Type
Guidance (12)
Guidance programme
Guidance programme
Early value assessment (2)
HealthTech guidance (4)
Interventional procedures guidance (1)
Technology appraisal guidance (8)
HealthTech approach
HealthTech approach
Early use (2)
Interventional procedure (1)
Routine use (1)
Apply filters
Showing 1 to 10 of 12
Sort by
Date
Title
Apply sorting
Guidance and quality standards in consultation
Title
Consultation
Type
Consultation end date
Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver
Interventional procedure consultation
HealthTech guidance
7 July 2026
Digital technologies to support home monitoring of vision changes for people with advanced dry age-related macular degeneration: early-use assessment
Draft guidance
HealthTech guidance
6 July 2026
Topical tapinarof for treating atopic dermatitis in people 2 years and over ID6713
Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators
Technology appraisal guidance
1 July 2026
Topical tapinarof for treating mild to severe plaque psoriasis ID6712
Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators
Technology appraisal guidance
30 June 2026
Software with artificial intelligence (AI)-derived algorithms to help interpret electroencephalograms (EEGs) for suspected epilepsy: early-use assessment
Draft guidance
HealthTech guidance
30 June 2026
Resmetirom for treating non-alcoholic steatohepatitis and liver fibrosis [ID6529]
Draft guidance
Technology appraisal guidance
30 June 2026
Teclistamab for treating relapsed or refractory multiple myeloma after 1 or more treatments ID6628
Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators
Technology appraisal guidance
29 June 2026
Mezigdomide with dexamethasone and carfilzomib for treating relapsed or refractory multiple myeloma after at least 1 line of treatment ID6513
Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators
Technology appraisal guidance
29 June 2026
Renal sympathetic denervation for resistant hypertension
Draft scope consultation
HealthTech guidance
29 June 2026
Xanomeline tartrate–trospium chloride for treating schizophrenia ID6716
Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators
Technology appraisal guidance
26 June 2026
Current page
1
2
Page
1
of
2
Next page
Results per page
10
25
50
All
Back to top